Evaluation of four clinical laboratory parameters for the diagnosis of myalgic encephalomyelitis

[1]  O. Fiehn,et al.  Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics , 2018, Scientific Reports.

[2]  C. Scheibenbogen,et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease. , 2018, Autoimmunity reviews.

[3]  J. Blomberg,et al.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model , 2018, Front. Immunol..

[4]  A. Finkelmeyer,et al.  Are current chronic fatigue syndrome criteria diagnosing different disease phenotypes? , 2017, PloS one.

[5]  Mark M. Davis,et al.  Cytokine signature associated with disease severity in chronic fatigue syndrome patients , 2017, Proceedings of the National Academy of Sciences.

[6]  I. Bileviciute-Ljungar,et al.  Unperturbed Cytotoxic Lymphocyte Phenotype and Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients , 2017, Front. Immunol..

[7]  H. Einsele,et al.  Robust 8-color flow cytometry panel reveals enhanced effector function of NKG2C+ CD57+ FcεRγ- NK cells in CMV seropositive human blood donors. , 2017, Immunobiology.

[8]  P. Stafford,et al.  Humoral Immunity Profiling of Subjects with Myalgic Encephalomyelitis Using a Random Peptide Microarray Differentiates Cases from Controls with High Specificity and Sensitivity , 2016, Molecular Neurobiology.

[9]  H. Ljunggren,et al.  NK Cell Responses to Human Tick-Borne Encephalitis Virus Infection , 2016, The Journal of Immunology.

[10]  Kefeng Li,et al.  Metabolic features of chronic fatigue syndrome , 2016, Proceedings of the National Academy of Sciences.

[11]  M. Fletcher,et al.  Illness progression in chronic fatigue syndrome: a shifting immune baseline , 2016, BMC Immunology.

[12]  E. Bosmans,et al.  Decreased Numbers of CD57+CD3- Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder. , 2016, In vivo.

[13]  C. Meisel,et al.  Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome , 2016, Brain, Behavior, and Immunity.

[14]  A. Palotás,et al.  Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome , 2016, Translational Psychiatry.

[15]  A. Prasad.  Macroscale intraspecific variation and environmental heterogeneity: analysis of cold and warm zone abundance, mortality, and regeneration distributions of four eastern US tree species , 2015, Ecology and evolution.

[16]  D. Staines,et al.  Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients , 2015, International journal of medical sciences.

[17]  M. Rajeevan,et al.  Pathway-focused genetic evaluation of immune and inflammation related genes with chronic fatigue syndrome. , 2015, Human immunology.

[18]  Michael M. Lederman,et al.  Soluble CD14 is a nonspecific marker of monocyte activation , 2015, AIDS.

[19]  A. Rizvanov,et al.  Cytokine expression provides clues to the pathophysiology of Gulf War illness and myalgic encephalomyelitis. , 2015, Cytokine.

[20]  Mady Hornig,et al.  Distinct plasma immune signatures in ME/CFS are present early in the course of illness , 2015, Science Advances.

[21]  P. Verbanck,et al.  Dimensions of pure chronic fatigue: psychophysical, cognitive and biological correlates in the chronic fatigue syndrome , 2014, European Journal of Applied Physiology.

[22]  M. Teixeira,et al.  The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases , 2014, Expert review of clinical immunology.

[23]  D. P. Lewis,et al.  Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort , 2014, Journal of internal medicine.

[24]  M. Berk,et al.  The Emerging Role of Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/cfs) , 2014, Molecular Neurobiology.

[25]  M. Maes,et al.  In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation. , 2013, Journal of affective disorders.

[26]  J. Montoya,et al.  Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology , 2013, Journal of Translational Medicine.

[27]  A. Blamire,et al.  Cerebral vascular control is associated with skeletal muscle pH in chronic fatigue syndrome patients both at rest and during dynamic stimulation☆ , 2013, NeuroImage: Clinical.

[28]  S. Kritchevsky,et al.  Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[29]  Lotti Tajouri,et al.  Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis , 2012, Journal of Translational Medicine.

[30]  P. Kalinski.  Regulation of Immune Responses by Prostaglandin E2 , 2012, The Journal of Immunology.

[31]  I. Mena,et al.  Myalgic encephalomyelitis: International Consensus Criteria , 2011, Journal of internal medicine.

[32]  L. Cannon-Albright,et al.  Evidence for a heritable predisposition to Chronic Fatigue Syndrome , 2011, BMC neurology.

[33]  A. Rademaker,et al.  CFS prevalence and risk factors over time , 2011, Journal of health psychology.

[34]  Jin-Mann S. Lin,et al.  The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs , 2011 .

[35]  H. Pircher,et al.  CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. , 2010, Blood.

[36]  F. Togo,et al.  Cytokines across the Night in Chronic Fatigue Syndrome with and without Fibromyalgia , 2010, Clinical and Vaccine Immunology.

[37]  O. Baskurt,et al.  Immune and hemorheological changes in Chronic Fatigue Syndrome , 2010, Journal of Translational Medicine.

[38]  J. Prechl,et al.  A novel, complement-mediated way to enhance the interplay between macrophages, dendritic cells and T lymphocytes. , 2009, Molecular immunology.

[39]  Mary Ann Fletcher,et al.  Plasma cytokines in women with chronic fatigue syndrome , 2009, Journal of Translational Medicine.

[40]  J. Andersson,et al.  ELISpot analysis of LPS-stimulated leukocytes: human granulocytes selectively secrete IL-8, MIP-1beta and TNF-alpha. , 2009, Journal of immunological methods.

[41]  Xinmin Cao,et al.  Cytokine profiling and Stat3 phosphorylation in epithelial-mesenchymal interactions between keloid keratinocytes and fibroblasts. , 2009, The Journal of investigative dermatology.

[42]  G. Opdenakker,et al.  Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation , 2008, The Journal of experimental medicine.

[43]  J. F. Siqueira,et al.  Natural killer cells and alterations in collagen density: signs of periradicular herpesvirus infection? , 2008, Clinical Oral Investigations.

[44]  L. Jason,et al.  The Economic impact of ME/CFS: Individual and societal costs , 2008, Dynamic medicine : DM.

[45]  N. Klimas,et al.  Chronic fatigue syndrome: Inflammation, immune function, and neuroendocrine interactions , 2007, Current rheumatology reports.

[46]  G. Taylor,et al.  Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3 , 2007, Proceedings of the National Academy of Sciences.

[47]  L. Yao,et al.  Prostaglandin E2 promotes degranulation‐independent release of MCP‐1 from mast cells , 2006, Journal of leukocyte biology.

[48]  G. Verleden,et al.  Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[49]  D. Tyrrell,et al.  Cytokines in parvovirus b19 infection as an aid to understanding chronic fatigue syndrome , 2003, Current pain and headache reports.

[50]  R. Phipps,et al.  Prostaglandins as modulators of immunity. , 2002, Trends in immunology.

[51]  P. Sullivan,et al.  A Twin Study of Chronic Fatigue , 2001, Psychosomatic medicine.

[52]  J. Vecchiet,et al.  Chronic fatigue syndrome following a toxic exposure. , 2001, The Science of the total environment.

[53]  R. Patarca,et al.  Cytokines and Chronic Fatigue Syndrome , 2001, Annals of the New York Academy of Sciences.

[54]  R. Stricker,et al.  Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. , 2001, Immunology letters.

[55]  G. De’ath,et al.  CLASSIFICATION AND REGRESSION TREES: A POWERFUL YET SIMPLE TECHNIQUE FOR ECOLOGICAL DATA ANALYSIS , 2000 .

[56]  Y. Yu,et al.  Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. , 1998, Journal of immunology.

[57]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[58]  D. Schadendorf,et al.  Human mast cells produce IL-8. , 1993, Journal of immunology.

[59]  R. L. Roper,et al.  A new view of prostaglandin E regulation of the immune response. , 1991, Immunology today.

[60]  C. Zachariae,et al.  Quantitative determination of IL-1 alpha-induced IL-8 mRNA levels in cultured human keratinocytes, dermal fibroblasts, endothelial cells, and monocytes. , 1991, The Journal of investigative dermatology.

[61]  Horrobin Df.  The role of essential fatty acids and prostaglandins in the premenstrual syndrome. , 1983 .

[62]  P. Flor-Henry,et al.  Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols , 2003 .

[63]  N. McGregor,et al.  Chronic Fatigue Syndrome Guidelines , 2003 .

[64]  R. Kitchens.  Role of CD14 in cellular recognition of bacterial lipopolysaccharides. , 2000, Chemical immunology.

[65]  I. Hickie,et al.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. , 1994, Annals of internal medicine.

[66]  K. R. Jones.  Direct and indirect costs. , 1994, Seminars for nurse managers.

[67]  K. Furuya,et al.  Prostaglandins and premenstrual syndrome. , 1992, Prostaglandins, leukotrienes, and essential fatty acids.

[68]  D. Bell,et al.  Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases. , 1991, Reviews of infectious diseases.

[69]  D. Horrobin.  The role of essential fatty acids and prostaglandins in the premenstrual syndrome. , 1983, The Journal of reproductive medicine.